DUSP22 Activators
DUSP22 Activators encompass a diverse array of chemical compounds that indirectly potentiate the functional activity of DUSP22 through modulation of various cellular signaling pathways. Forskolin, by increasing intracellular cAMP levels, activates PKA, which may phosphorylate substrates and create a favorable context for DUSP22 activity enhancement, given its role in dephosphorylating key signaling molecules. Similarly, Okadaic Acid and Calyculin A, by inhibiting PP1 and PP2A, can indirectly necessitate an upregulation of DUSP22 to restore phosphatase function balance within the cell. Sodium Orthovanadate and Pervanadate, functioning as phosphatase inhibitors, could amplify the need for DUSP22's phosphatase activity to counteract an overall increase in cellular phosphorylation levels. Phenylarsine Oxide and Cantharidin also target phosphatases, potentially redirecting the cellular dependency towards DUSP22-mediated dephosphorylation processes.
Furthermore, Endothall's inhibition of PP2A, Zoledronic Acid's impact on farnesyl pyrophosphate synthase, and Bisindolylmaleimide I's inhibition of PKC can all create a cellular environment that indirectly favors the enhancement of DUSP22's activity. This is because the cell might increase reliance on DUSP22 for regulating phosphorylation dynamics in response to altered signaling pathways. Inhibitors such as SP600125 and LY294002, which target JNK and PI3K respectively, could also contribute to a compensatory increase in DUSP22 activity. This is due to their ability to modify the balance of cellular signaling, highlighting the integrated nature of signaling networks where the modulation of one pathway can lead to enhanced activation of DUSP22 to maintain homeostasis in cellular signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by raising cAMP levels, leads to the activation of PKA. PKA can then phosphorylate substrates that may include DUSP22, thereby enhancing its phosphatase activity which regulates cellular responses by dephosphorylating specific substrates. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). Inhibition of these phosphatases can lead to a compensatory increase in DUSP22 activity to maintain cellular phosphatase function balance. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium Orthovanadate acts as a phosphatase inhibitor. By inhibiting a broad range of phosphatases, it might indirectly increase the need for DUSP22's activity in cells to counteract the heightened phosphorylation state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to Okadaic Acid, is a selective inhibitor of PP1 and PP2A. Its inhibition of these phosphatases could lead to a homeostatic increase in DUSP22 action to regulate the phosphorylation levels in the cell. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Phenylarsine Oxide is an inhibitor of tyrosine phosphatases. It may indirectly enhance DUSP22 activity by selectively blocking other phosphatases, thus shifting the cellular equilibrium to rely more on DUSP22 function. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin selectively inhibits PP2A and could therefore increase the cellular need for DUSP22 activity to maintain phosphatase function and cellular signaling homeostasis. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall is a PP2A inhibitor. By selectively inhibiting PP2A, it could lead to a compensatory increase in DUSP22 activity as the cell attempts to regulate the phosphorylation state of its proteins. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective inhibitor of Protein Kinase C (PKC). The inhibition of PKC can influence signaling pathways that may enhance the activity of DUSP22 in regulating cell proliferation and apoptosis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could lead to an upregulation of DUSP22 activity as the cell adjusts its signaling networks to compensate for the decreased PI3K signaling, thus enhancing the phosphatase function of DUSP22. | ||||||